Oryzon Genomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	22.11	28.35	5.62	12.26	21.32	28.72
Cash & Short-Term Investments	22.11	28.35	5.62	12.26	21.32	28.72
Cash Growth	479.52%	404.61%	-54.16%	-42.50%	-25.79%	-27.47%
Accounts Receivable	1.05	2.2	3.02	1.91	3.71	3.64
Inventory	0.02	0	0	0.01	0.01	0.1
Other Current Assets	0.28	0.11	0.11	0.1	0.13	0.13
Total Current Assets	23.45	30.67	8.75	14.28	25.16	32.61
Net Property, Plant & Equipment	0.38	0.38	0.36	0.48	0.61	0.68
Other Intangible Assets	113.09	109.22	98.23	89.9	75.84	60.25
Long-Term Investments	0.13	0.13	0.13	0.03	0.03	0.03
Other Long-Term Assets	4.66	4.13	2.39	2.22	2.05	1.81
Total Assets	141.7	144.52	109.85	106.9	103.7	95.38
Accounts Payable	8.37	7.32	5.76	8.42	11.48	7.04
Short-Term Debt	17.18	22.01	17.62	24.37	25.82	8.61
Current Portion of Leases	0.02	-	-	0.02	0.02	-
Other Current Liabilities	0	1.1	0.05	0.01	0.14	0.85
Total Current Liabilities	12.79	15.77	11.74	16.41	18.73	8.67
Long-Term Debt	5.89	6.76	7.45	6.28	10.27	13.35
Long-Term Leases	0	-	-	0.06	0.08	-
Other Long-Term Liabilities	4.8	4.15	2.48	2.53	2.05	2.38
Total Long-Term Liabilities	10.62	10.91	9.94	8.71	12.4	15.45
Total Liabilities	23.41	26.68	21.67	25.13	31.13	24.12
Common Stock	3.99	3.99	3.29	3.06	2.78	2.65
Treasury Stock	-5.8	-5.81	-2.03	-0.55	-0.62	-0.69
Additional Paid-in Capital	132.16	132.16	100.72	92.38	79.69	73.96
Accumulated Other Comprehensive Income	-	-	-	-1.8	-1	-
Retained Earnings	-26.03	-24.9	-20.97	-17.98	-14.42	-10.09
Total Common Shareholders' Equity	104.33	105.45	81	75.11	66.42	65.83
Minority Interest	13.97	12.4	7.17	6.67	6.15	5.44
Shareholders' Equity	118.29	117.85	88.17	81.77	72.57	71.26
Total Liabilities & Equity	141.7	144.52	109.85	106.9	103.7	95.38
Total Debt	23.1	28.76	25.07	30.72	36.19	21.97
Net Cash (Debt)	-0.99	-0.41	-19.45	-18.47	-14.87	6.76
Net Cash Growth	-	-	-	-	-	-68.14%
Net Cash Per Share	-0.01	-0.01	-0.31	-0.24	-0.27	0.13
Book Value	104.33	105.45	81	75.11	66.42	65.83
Book Value Per Share	1.36	1.42	1.29	0.97	1.21	1.25
Tangible Book Value	-8.77	-3.77	-17.22	-14.79	-9.42	5.57
Tangible Book Value Per Share	-0.11	-0.05	-0.27	-0.19	-0.17	0.11